Literature DB >> 19718463

Molecular diversity of anticoagulants from haematophagous animals.

Cho Yeow Koh1, R Manjunatha Kini.   

Abstract

To obtain blood meals, haematophagous animals are armed with potent pharmacological molecules to overcome several of their hosts' response systems. Among them, a large number of exogenous anticoagulants which target the haemostatic system have been identified and characterised. Studies on these anticoagulants have expanded our knowledge on the blood coagulation system, and provided a valuable source of antithrombotic therapeutic agents. Advances in genomic, transcriptomic, structural and proteomic tools greatly accelerated the discovery and analysis of the exogenous anticoagulants in recent years. The molecular diversity observed in these molecules is huge and is constantly expanding. In this review, we will provide an overview on the structure, function and mechanism of the exogenous anticoagulants from haematophagous animals and rationalise their molecular diversity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718463     DOI: 10.1160/TH09-04-0221

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  38 in total

1.  A novel targeted multi-functional fusion protein possesses inhibitory activities against bacteria, thrombin and platelet aggregation.

Authors:  Jiange Gao; Zongli Hu; Zhiping Zhao; Guanglei Liu; Yanrong Ren; Guoping Chen
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

2.  NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition.

Authors:  Viviane S De Paula; Nikolaos G Sgourakis; Ivo M B Francischetti; Fabio C L Almeida; Robson Q Monteiro; Ana Paula Valente
Journal:  Blood       Date:  2019-05-27       Impact factor: 22.113

3.  An unusual cause of chest discomfort: case report of oesophageal hirudiniasis.

Authors:  Cristóvão Figueiredo; Joana Alves; Cláudia Carvalho; António Sarmento
Journal:  J Parasit Dis       Date:  2016-08-29

4.  Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.

Authors:  Eric Calvo; Daniella M Mizurini; Anderson Sá-Nunes; José M C Ribeiro; John F Andersen; Ben J Mans; Robson Q Monteiro; Michail Kotsyfakis; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

5.  Tyrosine sulfation modulates activity of tick-derived thrombin inhibitors.

Authors:  Robert E Thompson; Xuyu Liu; Jorge Ripoll-Rozada; Noelia Alonso-García; Benjamin L Parker; Pedro José Barbosa Pereira; Richard J Payne
Journal:  Nat Chem       Date:  2017-03-20       Impact factor: 24.427

6.  Nitrophorin 2, a factor IX(a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis.

Authors:  Daniella M Mizurini; Ivo M B Francischetti; John F Andersen; Robson Q Monteiro
Journal:  Thromb Haemost       Date:  2010-09-13       Impact factor: 5.249

7.  Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo.

Authors:  Dongying Ma; Daniella M Mizurini; Teresa C F Assumpção; Yuan Li; Yanwei Qi; Michail Kotsyfakis; José M C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

Review 8.  Structure and mechanism in salivary proteins from blood-feeding arthropods.

Authors:  John F Andersen
Journal:  Toxicon       Date:  2009-11-26       Impact factor: 3.033

9.  Tick spit shines a light on the initiation of coagulation.

Authors:  Maria M Aleman; Alisa S Wolberg
Journal:  Circulation       Date:  2013-07-01       Impact factor: 29.690

10.  More than just one: multiplicity of Hirudins and Hirudin-like Factors in the Medicinal Leech, Hirudo medicinalis.

Authors:  Christian Müller; Katharina Mescke; Stephanie Liebig; Hala Mahfoud; Sarah Lemke; Jan-Peter Hildebrandt
Journal:  Mol Genet Genomics       Date:  2015-08-13       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.